Pfizer and BioNTech win bid to invalidate CureVac’s COVID vaccine patents in UK

Pfizer and its partner BioNTech won their bid to invalidate CureVac’s COVID vaccine patents in the High Court in London. Pfizer and BioNTech had filed their lawsuit in September 2022 over patents related to messenger RNA technology.

Compartir esta publicacion:

ENTRADAS POPULARES
SÍGANOS
Danos like en facebook
Síganos en Twitter
Suscríbase a nuestro canal
Tik Tok
TRANSMISIÓN EN VIVO